scholarly article | Q13442814 |
P356 | DOI | 10.1097/01.AIDS.0000238407.00874.DC |
P698 | PubMed publication ID | 16868442 |
P50 | author | Harvey M. Friedman | Q89912954 |
Gregory P Bisson | Q91276180 | ||
Jordan B Strom | Q91986877 | ||
Scarlett Bellamy | Q102312298 | ||
P2093 | author name string | Brian L Strom | |
Ian Frank | |||
Ndwapi Ndwapi | |||
Tendani Gaolathe | |||
Robert Gross | |||
Diana Dickinson | |||
Jordan B Strom | |||
Rachel Weinstein | |||
Caitlin Rollins | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virology | Q7215 |
anti-retroviral agent | Q50430310 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 1613-1619 | |
P577 | publication date | 2006-08-01 | |
P1433 | published in | AIDS | Q4651863 |
P1476 | title | Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy | |
P478 | volume | 20 |
Q34464667 | A clinical prediction score in addition to WHO criteria for anti-retroviral treatment failure in resource-limited settings--experience from Lesotho. |
Q44265409 | A model for reduced HIV-1 viral load monitoring in resource-limited settings |
Q64280420 | A prospective study to evaluate efficacy of second-line antiretroviral therapy given to human immunodeficiency virus patients at Antiretroviral Therapy Plus Centre in India |
Q37043399 | Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy |
Q36793821 | Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults. |
Q34814795 | Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy |
Q37325907 | CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia |
Q46643116 | Can the initial success of the Malawi ART scale-up programme be sustained? The example of Queen Elizabeth Central Hospital, Blantyre |
Q42204657 | Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors? |
Q37955946 | Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less |
Q37025655 | Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa |
Q28730357 | Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe |
Q37147686 | Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria |
Q36576089 | Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda |
Q37165025 | Efficacy of antiretroviral therapy in Africa: effect on immunological and virological outcome measures -- a meta-analysis. |
Q37149013 | Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy |
Q37288419 | Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda |
Q84420336 | Five-year outcomes of the China National Free Antiretroviral Treatment Program |
Q34735495 | HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City |
Q34731031 | Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality |
Q81161975 | Monitoring antiretroviral failure in resource-poor settings |
Q33497943 | Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay |
Q33862806 | Mortality after failure of antiretroviral therapy in sub-Saharan Africa |
Q37405560 | Novel pH sensing semiconductor for point-of-care detection of HIV-1 viremia |
Q37658177 | Optimal Allocation of Gold Standard Testing under Constrained Availability: Application to Assessment of HIV Treatment Failure |
Q28472810 | Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy |
Q34042986 | Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection. |
Q34518252 | Prediction based classification for longitudinal biomarkers |
Q33751459 | Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana |
Q36083869 | Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa |
Q53086924 | State of the ART: clinical efficacy and improved quality of life in the public antiretroviral therapy program, Free State province, South Africa. |
Q37602847 | Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries |
Q36090721 | Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy |
Q35099443 | Systematic review of the performance of HIV viral load technologies on plasma samples |
Q34049901 | The efficacy of a computerized assessment of medication adherence in active substance users |
Q41693941 | Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam |
Q33349204 | Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting |
Q35541563 | Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial |
Q33622913 | Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation |
Search more.